Therachon therachon.com


Public lists: Smart Money VCs (6328)

Therachon is a global biotechnology company focused on developing treatments for rare, genetic diseases that currently have no available treatments. The company's lead pipeline candidate, TA-46, is a novel protein therapy in development for achondroplasia, the most common form of short-limbed dwarfism. This rare genetic condition affects about one in 25,000 children and is caused by a genetic mutation of the FGFR3 receptor, which stunts child bone growth. Therachon is committed to translating th...Show all

Therachon is a global biotechnology company focused on developing treatments for rare, genetic diseases that currently have no available treatments. The company's lead pipeline candidate, TA-46, is a novel protein therapy in development for achondrop...Show all

Company (Alive / Active)

Phone:

Fax:

Aeschenvorstadt 36

Basel, 4051
Switzerland

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Therachon $100M Aug 9, 2018

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Therachon Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 11 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Soluble fgfr3 decoys for treating skeletal growth disorders Jan 07, 2016 Application